Shin Yamashita
Overview
Explore the profile of Shin Yamashita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Otsu Y, Yamashita S, Kuramoto T, Shimamatsu K, Morioka M
Cureus
. 2024 Dec;
16(11):e73198.
PMID: 39650895
Metastatic renal cell carcinomas (RCC) of the skull are relatively rare. Here, we present a rare case of a skull tumor due to metastatic RCC coexisting with a sphenoid ridge...
2.
Otsu Y, Yamakawa Y, Eto T, Yamashita S, Kuramoto T, Sakata K, et al.
J Neuroendovasc Ther
. 2024 Sep;
18(9):245-249.
PMID: 39309172
Objective: Internal carotid artery (ICA) agenesis has been classified into six types: A-F. Type F demonstrates distal reconstitution of the ICA via anastomosis with distal branches of the external carotid...
3.
Kajiwara S, Hirohata M, Takeuchi Y, Fujimura N, Yamashita S, Nakamura Y, et al.
J Neuroendovasc Ther
. 2023 Jul;
14(7):249-254.
PMID: 37502618
Objective: Stent-assisted aneurysmal embolization (SAAE) is an effective treatment for aneurysms with a low risk of recurrence. In rare cases, retreatment is necessary due to recanalization of blood flow into...
4.
Negoto T, Terachi S, Baba Y, Yamashita S, Kuramoto T, Morioka M
World Neurosurg
. 2018 Apr;
113:387.
PMID: 29702955
No abstract available.
5.
Negoto T, Terachi S, Baba Y, Yamashita S, Kuramoto T, Morioka M
World Neurosurg
. 2017 Dec;
111:227-234.
PMID: 29288846
Background: Brainstem cavernomas (BSCs) are rare and difficult to treat. The treatment strategy for symptomatic lesions in elderly patients remains unclear. In this review, we discuss the optimal treatment strategy...
6.
Maeshima A, Nakasatomi M, Henmi D, Yamashita S, Kaneko Y, Kuroiwa T, et al.
CEN Case Rep
. 2017 May;
1(1):7-11.
PMID: 28509146
Castleman's disease is a benign lymphoproliferative disorder in which interleukin-6 (IL-6), a pleiotropic proinflammatory cytokine, is thought to play a pathogenetic role. Presented is the case of a 72-year-old man...
7.
Katayama K, Yamashita S, Iwamoto E, Ishida K
Clin Physiol Funct Imaging
. 2014 Sep;
36(1):60-9.
PMID: 25257848
The purpose of this study was to elucidate the effect of acute aerobic exercise performed under hypoxic conditions on flow-mediated dilation (FMD) in the inactive limb. Seven males participated in...
8.
Maeshima A, Mishima K, Yamashita S, Nakasatomi M, Miya M, Sakurai N, et al.
Biomed Res Int
. 2014 Jun;
2014:376191.
PMID: 24883308
Activin, a member of the TGF-β superfamily, regulates cell growth and differentiation in various cell types. Activin A acts as a negative regulator of renal development as well as tubular...
9.
Iwamoto E, Katayama K, Yamashita S, Oshida Y, Ishida K
Eur J Appl Physiol
. 2013 Jul;
113(10):2565-75.
PMID: 23864526
Purpose: This study aimed to elucidate the effects of hypoxia on the pattern of oscillatory blood flow in the inactive limb during constant-load dynamic exercise. We hypothesised that retrograde blood...
10.
Katayama K, Yamashita S, Ishida K, Iwamoto E, Koike T, Saito M
Am J Physiol Regul Integr Comp Physiol
. 2013 Jan;
304(5):R374-82.
PMID: 23283938
The purpose of the present study was to clarify the influence of inspiratory resistive breathing during exercise under hypoxic conditions on muscle sympathetic nerve activity (MSNA) and blood pressure (BP)....